Back

Cardiovascular medication after coronary computed tomography angiography: Impact of the 2019 ESC guidelines

31 August 2026 (14:15 - 14:45)
Organised by: Logo
Congress Presentation Part of: Multimodal approaches to coronary artery disease: from clinical parameters, biomarkers, and imaging to clinical management Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Mikael Johansson

(Sweden)

4 More presentations in this session

Presentation thumbnail
Same-day discharge after percutaneous coronary intervention in France: a nationwide analysis from the France PCI registry
Doctor T. Roussel (Marseille, FR)
Abstract
Presentation thumbnail
Comprehensive cardiac evaluation by perfusion CMR improves risk prediction in chest pain patients compared to myocardial perfusion SPECT
Mr M. Kraen (Malmo, SE)
Abstract
Presentation thumbnail
Circulating biomarkers of endothelial injury and microvascular dysfunction in patients with angina and non-obstructive coronary arteries
Doctor J. Uzokov (Tashkent, UZ)
Abstract
Presentation thumbnail
Management of chronic coronary syndromes: comparison of Italian and non-Italian cohort, insight from the EORP EURECA imaging registry.
Doctor N. Carrabba (Florence, IT)
Abstract

Access the full session

Session thumbnail
Multimodal approaches to coronary artery disease: from clinical parameters, biomarkers, and imaging to clinical management

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Medication adjustments after cardiac computed tomography angiography for the screening of cardiac allograft vasculopathy
29 June 2021
thumbnail
Congress Presentation
Immediate implementation of three 2019 european society of cardiology guidelines in daily practice
27 August 2021
thumbnail
Congress Presentation
Patients adherence to the therapy after acute coronary syndrome undergoing PCI and its impact on hospitalizations and all- cause mortality during one year of follow up
29 June 2021
thumbnail
Congress Presentation
Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: relationship with all-cause mortality
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources